LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 80 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,727,756 | -52.6% | 13,420,242 | +2.6% | 0.00% | 0.0% |
| Q2 2023 | $41,600,101 | +42.9% | 13,081,793 | +6.0% | 0.00% | 0.0% |
| Q1 2023 | $29,115,634 | -31.0% | 12,337,133 | +1.4% | 0.00% | 0.0% |
| Q4 2022 | $42,226,478 | -50.9% | 12,169,014 | +3.8% | 0.00% | -66.7% |
| Q3 2022 | $85,959,000 | +31.8% | 11,727,102 | +17.3% | 0.00% | +50.0% |
| Q2 2022 | $65,198,000 | +65.3% | 9,999,713 | +28.0% | 0.00% | +100.0% |
| Q1 2022 | $39,438,000 | +154.8% | 7,809,490 | +290.6% | 0.00% | – |
| Q4 2021 | $15,476,000 | -26.7% | 1,999,452 | +40.1% | 0.00% | -100.0% |
| Q3 2021 | $21,118,000 | +425.2% | 1,426,897 | +476.3% | 0.00% | – |
| Q2 2021 | $4,021,000 | – | 247,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $29,638,628 | 28.72% |
| Orland Properties Ltd | 15,093,969 | $22,188,134 | 11.75% |
| Foresite Capital Management IV, LLC | 8,784,813 | $12,913,675 | 7.17% |
| MIC Capital Management UK LLP | 1,740,569 | $2,558,636 | 0.58% |
| Alphabet Inc. | 5,865,125 | $8,621,733 | 0.55% |
| HSG Holding Ltd | 3,045,997 | $4,477,616 | 0.48% |
| Clarius Group, LLC | 399,168 | $586,777 | 0.06% |
| CAXTON ASSOCIATES LP | 198,477 | $291,761 | 0.04% |
| XTX Topco Ltd | 114,720 | $168,638 | 0.03% |
| BBR PARTNERS, LLC | 164,041 | $241,140 | 0.03% |